LeafNLP Demos
Back to explore

Report #2878367

Received Dec 17, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
17 yrs
State
IA
Recovered
Recovered
Vaccinated
May 7, 2025
Onset
May 7, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (HEPLISAV-B)DYNAVAX TECHNOLOGIES CORPORATIONUNK945665—

Symptoms (2)

No adverse eventProduct administered to patient of inappropriate age

Symptom narrative

Patient received HEPLISAV-B at age 17; Initial report received on 12-Nov-2025. A medical assistant reported that a 17-year-old female received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. No medical history or concomitant medications were reported. On 07-May-2025, the patient received a dose of a hepatitis B vaccine [HEPLISAV-B (lot number 945665, expiration date 31-Jan-2027, and NDC number 43528-003-05; site not provided)] intramuscularly. The patient was 17 years old at the time of immunization. No side effects were reported. No additional information was reported. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.